BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33382187)

  • 1. Noonan syndrome patients beyond the obvious phenotype: A potential unfavorable metabolic profile.
    Noronha RM; Villares SMF; Torres N; Quedas EPS; Homma TK; Albuquerque EVA; Moraes MB; Funari MFA; Bertola DR; Jorge AAL; Malaquias AC
    Am J Med Genet A; 2021 Mar; 185(3):774-780. PubMed ID: 33382187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation.
    Bessis D; Miquel J; Bourrat E; Chiaverini C; Morice-Picard F; Abadie C; Manna F; Baumann C; Best M; Blanchet P; Bursztejn AC; Capri Y; Coubes C; Giuliano F; Guillaumont S; Hadj-Rabia S; Jacquemont ML; Jeandel C; Lacombe D; Mallet S; Mazereeuw-Hautier J; Molinari N; Pallure V; Pernet C; Philip N; Pinson L; Sarda P; Sigaudy S; Vial Y; Willems M; Geneviève D; Verloes A; Cavé H
    Br J Dermatol; 2019 Jun; 180(6):1438-1448. PubMed ID: 30417923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
    Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
    Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile in Noonan syndrome and related disorders: trend by age, sex and genotype.
    Tamburrino F; Mazzanti L; Scarano E; Gibertoni D; Sirolli M; Zioutas M; Schiavariello C; Perri A; Mantovani A; Rossi C; Tartaglia M; Pession A
    Front Endocrinol (Lausanne); 2023; 14():1209339. PubMed ID: 37588986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
    Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
    BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation Spectrum and Phenotypic Features in Noonan Syndrome with PTPN11 Mutations: Definition of Two Novel Mutations.
    Atik T; Aykut A; Hazan F; Onay H; Goksen D; Darcan S; Tukun A; Ozkinay F
    Indian J Pediatr; 2016 Jun; 83(6):517-21. PubMed ID: 26817465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noonan syndrome: Severe phenotype and PTPN11 mutations.
    Carrasco Salas P; Gómez-Molina G; Carreto-Alba P; Granell-Escobar R; Vázquez-Rico I; León-Justel A
    Med Clin (Barc); 2019 Jan; 152(2):62-64. PubMed ID: 29703613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
    Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
    Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.
    Papadopoulos G; Papadopoulou A; Kosma K; Papadimitriou A; Papaevangelou V; Kanaka-Gantenbein C; Bountouvi E; Kitsiou-Tzeli S
    Eur J Pediatr; 2022 Oct; 181(10):3691-3700. PubMed ID: 35904599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
    Jongmans MC; van der Burgt I; Hoogerbrugge PM; Noordam K; Yntema HG; Nillesen WM; Kuiper RP; Ligtenberg MJ; van Kessel AG; van Krieken JH; Kiemeney LA; Hoogerbrugge N
    Eur J Hum Genet; 2011 Aug; 19(8):870-4. PubMed ID: 21407260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].
    Ferreira LV; Souza SA; Montenegro LR; Arnhold IJ; Pasqualini T; Heinrich JJ; Keselman AC; Mendonça BB; Jorge AA
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):450-6. PubMed ID: 17546245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
    Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.
    Essawi ML; Ismail MF; Afifi HH; Kobesiy MM; El Kotoury A; Barakat MM
    J Formos Med Assoc; 2013 Nov; 112(11):707-12. PubMed ID: 24183200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders.
    Lorca R; Pannone L; Cuesta-Llavona E; Bocchinfuso G; Rodríguez-Reguero J; Carpentieri G; Hernando I; Flex E; Tartaglia M; Coto E; Gómez J; Martinelli S
    Clin Genet; 2021 Mar; 99(3):457-461. PubMed ID: 33354767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients.
    Ferreira LV; Souza SC; Montenegro LR; Malaquias AC; Arnhold IJ; Mendonca BB; Jorge AA
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):426-31. PubMed ID: 18331608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital sensorineural hearing loss as the initial presentation of
    Gao X; Huang SS; Qiu SW; Su Y; Wang WQ; Xu HY; Xu JC; Kang DY; Dai P; Yuan YY
    J Med Genet; 2021 Jul; 58(7):465-474. PubMed ID: 32737134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent ganglioneuroma in PTPN11-associated Noonan syndrome: A case report and literature review.
    Morales-Rosado JA; Singh H; Olson RJ; Larsen BT; Hager MM; Klee EW; Dhamija R
    Am J Med Genet A; 2021 Jun; 185(6):1883-1887. PubMed ID: 33779033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
    Bertelloni S; Baroncelli GI; Dati E; Ghione S; Baldinotti F; Toschi B; Simi P
    Hormones (Athens); 2013; 12(1):86-92. PubMed ID: 23624134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hotspots in PTPN11 Gene Among Indian Children With Noonan Syndrome.
    Narayanan DL; Pandey H; Moirangthem A; Mandal K; Gupta R; Puri RD; Patil SJ; Phadke SR
    Indian Pediatr; 2017 Aug; 54(8):638-643. PubMed ID: 28607217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.